Regulatory T cells are redirected to kill glioblastoma by an EGFRviii-targeted bispecific antibody

36Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Regulatory T cells (Tregs) play a central role in in tumor escape from immunosurveillance. We report that a bispecific T-cell engager (BiTE) targeting a mutated form of the epidermal growth factor receptor, i.e., EGFRvIII, potently redirects Tregs to kill glioblastoma through the granzyme-perforin pathway. © 2013 Landes Bioscience.

Cite

CITATION STYLE

APA

Choi, B. D., Gedeon, P. C., Sanchez-Perez, L., Bigner, D. D., & Sampson, J. H. (2013). Regulatory T cells are redirected to kill glioblastoma by an EGFRviii-targeted bispecific antibody. OncoImmunology, 2(12), 1–2. https://doi.org/10.4161/onci.26757

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free